Insider · CIK 0001781149
John Kiely
Files at AMRX (Amneal Pharmaceuticals, Inc.). First filing Nov 26, 2024, latest Aug 28, 2025.
John Kiely files SEC Form 4 as director at AMRX (Amneal Pharmaceuticals, Inc.). Since Nov 26, 2024, John Kiely has reported 0 open-market buys worth $0 and 3 open-market sells worth $818k, the latest filed on Aug 28, 2025.
A track record needs three past buys with six months of prices behind them; John Kiely has 0, so none is measured yet.
The newest scored trade: sold $295k of AMRX on Aug 27, 2025, filed Aug 28, 2025, scored 49 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AMRX: Amneal Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | Amneal Pharmaceuticals, Inc. | $295k 32,000 shares | -12% | +34% from low-2% from high | |
| 51Moderate | Amneal Pharmaceuticals, Inc. | $380k 50,000 shares | -16% | +9% from low-18% from high | |
| 26Weak | Amneal Pharmaceuticals, Inc. | $143k 17,058 shares | -6% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 27, 2025 | AMRX Amneal Pharmaceuticals, Inc. | 32,000 0.01% of outstanding | $294k | Aug 27, 2025 | none |
| May 12, 2025 | AMRX Amneal Pharmaceuticals, Inc. | 50,000 0.02% of outstanding | $379k | May 12, 2025 | none |
| Nov 22, 2024 | AMRX Amneal Pharmaceuticals, Inc. | 17,058 0.01% of outstanding | $142k | Nov 22, 2024 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +34,819 | - | - | 260,252 | May 8, 2026 |
| May 7, 2026 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -34,819 | $0.00 | $0 | 0 | May 8, 2026 |
| May 6, 2026 | AMRX Amneal Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +19,824 | $0.00 | $0 | 19,824 | May 8, 2026 |
| Aug 27, 2025 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -32,000 | $9.23 | $295k | 225,433 | Aug 28, 2025 |
| May 12, 2025 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -50,000 | $7.59 | $380k | 257,433 | May 13, 2025 |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +40,258 | - | - | 307,433 | May 8, 2025 |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -40,258 | $0.00 | $0 | 0 | May 8, 2025 |
| May 6, 2025 | AMRX Amneal Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +34,819 | $0.00 | $0 | 34,819 | May 8, 2025 |
| Nov 22, 2024 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Class A Common Stock | +28,506 | $4.76 | $136k | 284,233 | Nov 26, 2024 |
| Nov 22, 2024 | AMRX Amneal Pharmaceuticals, Inc. | SOpen-market sale Class A Common Stock | -17,058 | $8.38 | $143k | 267,175 | Nov 26, 2024 |
| Nov 22, 2024 | AMRX Amneal Pharmaceuticals, Inc. | MOption exercise Stock Optionderivative | -28,506 | $0.00 | $0 | 0 | Nov 26, 2024 |
Questions about John Kiely
Answered from the filings on this page, as of the latest one.
Is John Kiely buying or selling?
Not in the last 12 months. John Kiely's latest open-market trade on SEC Form 4 was sold $295k of AMRX on Aug 27, 2025.
How did John Kiely's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Kiely has 0.
Where does John Kiely file Form 4?
John Kiely has filed Form 4 at AMRX (Amneal Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.